1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Shift from volume to value based care
5.2.2. Delays in drug development and the subsequent increase in development costs
5.2.3. Drug safety and effectiveness after clinical trials
5.3. Restraints
5.3.1. Reluctance to rely on real-world studies
5.4. Opportunities
5.4.1. Rising focus on end-to-end RWE services
5.4.2. Emerging roles of wearable devices and AI in RWE
5.5. Challenges
5.5.1. Lack of universally accepted methodological standards and data processing infrastructure

6. Real World Evidence Solution Market, by Component
6.1. Introduction
6.2. Data Set
6.2.1. Claims Data
6.2.2. Clinical Settings Data
6.2.3. Patient-Powered Data
6.2.4. Pharmacy Data
6.3. Services

7. Real World Evidence Solution Market, by Therapeutic Area
7.1. Introduction
7.2. Cardiovascular
7.3. Immunology
7.4. Infectious Diseases
7.5. Neurology
7.6. Oncology

8. Real World Evidence Solution Market, by End-User
8.1. Introduction
8.2. Biopharmaceutical Company
8.3. Clinical & Life Sciences Organization
8.4. Diagnostics or Medical Device Company

9. Americas Real World Evidence Solution Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Real World Evidence Solution Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand

11. Europe, Middle East & Africa Real World Evidence Solution Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Quadrant
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Certara, L.P.
13.2. Clinigen Group PLC
13.3. Cognizant Technology Solutions Corp.
13.4. HealthiVibe, LLC
13.5. IBM Corporation
13.6. ICON PLC
13.7. IQVIA
13.8. Mercy Technology Services
13.9. Oracle Corporation
13.10. PAREXEL International Corporation
13.11. Pharmaceutical Product Development, LLC
13.12. SAS Institute, Inc.
13.13. Sciformix Corporation
13.14. Syneos Health
13.15. Turacoz

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2019 VS 2025 (USD MILLION)
FIGURE 2. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 3. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: MARKET DYNAMICS
FIGURE 4. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2019 VS 2025 (%)
FIGURE 5. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2019 VS 2025 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2025
FIGURE 7. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2017-2025 (USD MILLION)
FIGURE 8. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, BY REGION, 2019 VS 2025 (USD MILLION)
FIGURE 9. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLAIMS DATA, 2017-2025 (USD MILLION)
FIGURE 10. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLAIMS DATA, BY REGION, 2019 VS 2025 (USD MILLION)
FIGURE 11. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLINICAL SETTINGS DATA, 2017-2025 (USD MILLION)
FIGURE 12. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLINICAL SETTINGS DATA, BY REGION, 2019 VS 2025 (USD MILLION)
FIGURE 13. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY PATIENT-POWERED DATA, 2017-2025 (USD MILLION)
FIGURE 14. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY PATIENT-POWERED DATA, BY REGION, 2019 VS 2025 (USD MILLION)
FIGURE 15. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY PHARMACY DATA, 2017-2025 (USD MILLION)
FIGURE 16. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY PHARMACY DATA, BY REGION, 2019 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY SERVICES, 2017-2025 (USD MILLION)
FIGURE 18. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY SERVICES, BY REGION, 2019 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2019 VS 2025 (%)
FIGURE 20. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2019 VS 2025 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2025
FIGURE 22. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CARDIOVASCULAR, 2017-2025 (USD MILLION)
FIGURE 23. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2019 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY IMMUNOLOGY, 2017-2025 (USD MILLION)
FIGURE 25. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2019 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2025 (USD MILLION)
FIGURE 27. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2019 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY NEUROLOGY, 2017-2025 (USD MILLION)
FIGURE 29. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY NEUROLOGY, BY REGION, 2019 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY ONCOLOGY, 2017-2025 (USD MILLION)
FIGURE 31. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY ONCOLOGY, BY REGION, 2019 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2019 VS 2025 (%)
FIGURE 33. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2019 VS 2025 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2025
FIGURE 35. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY BIOPHARMACEUTICAL COMPANY, 2017-2025 (USD MILLION)
FIGURE 36. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY BIOPHARMACEUTICAL COMPANY, BY REGION, 2019 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLINICAL & LIFE SCIENCES ORGANIZATION, 2017-2025 (USD MILLION)
FIGURE 38. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLINICAL & LIFE SCIENCES ORGANIZATION, BY REGION, 2019 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DIAGNOSTICS OR MEDICAL DEVICE COMPANY, 2017-2025 (USD MILLION)
FIGURE 40. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DIAGNOSTICS OR MEDICAL DEVICE COMPANY, BY REGION, 2019 VS 2025 (USD MILLION)
FIGURE 41. AMERICAS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 42. ARGENTINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 43. BRAZIL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 44. CANADA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 45. MEXICO REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 46. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 47. ASIA-PACIFIC REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 48. AUSTRALIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 49. CHINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 50. INDIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 51. INDONESIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 52. JAPAN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 53. MALAYSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 54. PHILIPPINES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 55. SOUTH KOREA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 56. THAILAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 57. EUROPE, MIDDLE EAST & AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 58. FRANCE REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 59. GERMANY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 60. ITALY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 61. NETHERLANDS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 62. QATAR REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 63. RUSSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 64. SAUDI ARABIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 65. SOUTH AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 66. SPAIN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 67. UNITED ARAB EMIRATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 68. UNITED KINGDOM REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 69. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: FPNV POSITIONING MATRIX
FIGURE 70. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: SHARE, BY QUADRANT, 2019
FIGURE 71. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 4. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 5. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, BY REGION, 2017-2025 (USD MILLION)
TABLE 6. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLAIMS DATA, BY REGION, 2017-2025 (USD MILLION)
TABLE 7. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLINICAL SETTINGS DATA, BY REGION, 2017-2025 (USD MILLION)
TABLE 8. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY PATIENT-POWERED DATA, BY REGION, 2017-2025 (USD MILLION)
TABLE 9. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY PHARMACY DATA, BY REGION, 2017-2025 (USD MILLION)
TABLE 10. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY SERVICES, BY REGION, 2017-2025 (USD MILLION)
TABLE 11. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 12. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2017-2025 (USD MILLION)
TABLE 13. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2017-2025 (USD MILLION)
TABLE 14. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2017-2025 (USD MILLION)
TABLE 15. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY NEUROLOGY, BY REGION, 2017-2025 (USD MILLION)
TABLE 16. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY ONCOLOGY, BY REGION, 2017-2025 (USD MILLION)
TABLE 17. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 18. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY BIOPHARMACEUTICAL COMPANY, BY REGION, 2017-2025 (USD MILLION)
TABLE 19. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLINICAL & LIFE SCIENCES ORGANIZATION, BY REGION, 2017-2025 (USD MILLION)
TABLE 20. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DIAGNOSTICS OR MEDICAL DEVICE COMPANY, BY REGION, 2017-2025 (USD MILLION)
TABLE 21. AMERICAS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 22. ARGENTINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 23. BRAZIL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 24. CANADA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 25. MEXICO REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 26. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 27. ASIA-PACIFIC REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 28. AUSTRALIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 29. CHINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 30. INDIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 31. INDONESIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 32. JAPAN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 33. MALAYSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 34. PHILIPPINES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 35. SOUTH KOREA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 36. THAILAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 37. EUROPE, MIDDLE EAST & AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 38. FRANCE REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 39. GERMANY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 40. ITALY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 41. NETHERLANDS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 42. QATAR REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 43. RUSSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 44. SAUDI ARABIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 45. SOUTH AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 46. SPAIN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 47. UNITED ARAB EMIRATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 48. UNITED KINGDOM REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 49. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: SCORES
TABLE 50. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: BUSINESS STRATEGY
TABLE 51. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: PRODUCT SATISFACTION
TABLE 52. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: RANKING
TABLE 53. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: SHARE, BY QUADRANT, 2019
TABLE 54. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: MERGER & ACQUISITION
TABLE 55. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 56. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 57. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: INVESTMENT & FUNDING
TABLE 58. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 59. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: LICENSE & PRICING

Companies Mentioned

Certara, L.P.
Clinigen Group PLC
Cognizant Technology Solutions Corp.
HealthiVibe, LLC
IBM Corporation
ICON PLC
IQVIA
Mercy Technology Services
Oracle Corporation
PAREXEL International Corporation
Pharmaceutical Product Development, LLC
SAS Institute, Inc.
Sciformix Corporation
Syneos Health
Turacoz